GlassScriptPhysician profile
Derick R Fenton
NPI 1750673539
$21,243.12
in general payments reported to CMS, 2019-2025
12 companies · $62.19 in 2025
The $62.19 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103 · 2020: $1,975 · 2021: $3,027 · 2022: $57.72 · 2023: $4,319 · 2024: $12K · 2025: $62.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $15K · Food and Beverage: $906 · Travel and Lodging: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $15,000.00 |
| Food and Beverage | $905.93 |
| Travel and Lodging | $174.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $20,666.87 | 2019-2025 | Da Vinci Surgical System |
| Astellas Pharma US INC | $140.12 | 2023-2024 | Veozah |
| Abbvie INC. | $136.38 | 2019-2024 | |
| Hologic Sales and Service, LLC | $105.66 | 2020-2023 | Novasure, Omni Hysteroscope, Myosure Tissue Removal Device |
| Coloplast Corp | $38.92 | 2023 | Altis |
| Pfizer INC. | $31.50 | 2024 | |
| Conmed Corporation | $30.69 | 2023 | Airseal |
| Mentor Worldwide LLC | $26.09 | 2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Organon LLC | $22.45 | 2022 | |
| Boston Scientific Corporation | $17.10 | 2025 | Axonics |
| Bayer Healthcare Pharmaceuticals INC. | $15.87 | 2021 | |
| Agile Therapeutics, INC. | $11.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derick Fenton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.